1. Purpose:
Evaluation of the indication of the study with bone densitometry in the assessment of fracture risk 
 (during the period 2017-2018).

2. Methods
Design: Longitudinal evaluation: Palmer’s Quality Cycle
Setting: An urban health care center.
Population and Sample:
Population and sample: densitometry (Dx) requested (years 2017-2018) (n = 20, 22)
Interventions:
-Internal evaluation, dimensions:scientific-technica, quality, adequacy, accessibility, continuity of care; data related to the care process and intermediate results; explicit, evidence-based procedural criteria. Subjects: analysis of coverage.  Analysis on the evolution of treatment compliance. The Z statistical test for comparing proportions, alfa 0,05.

3.  Results


It has been reduced to less than half of the % of Dx that would not be indicated: from 30% to 14%. If we include those of doubtful indication in the first field work, the reduction would be 45% to 15%, that is, less than one third.

The number of Dx requested has decreased slightly (17.41%): fieldwork 3 months in 2017: 20 Dx (6.66 / month), fieldwork 4 months in 2018: 22 Dx (5.50) / month ).

4-Conclusions

A qualitative level was observed in the second field work that a study request number with Dx, its objective was to control the BMD in patients, who are following a specific antiresorptive treatment, but there was no previous diagnosis of objectified osteoporosis, many, have been scheduled from the 2nd level of assistance. In this case, the study with Dx also provides a value in the suppression of the treatment

EVALUATION OF THE INDICATION OF THE STUDY WITH BONE DENSITOMETRY IN THE ASSESSMENT OF FRACTURE